Health Companies
Mindoo ๐ง๐ช 
Allos ๐ฌ๐ง 
Antiverse ๐ฌ๐ง 
Sectra ๐ 
Sorcero ๐ 
Qt Sense ๐ณ๐ฑ 
Lifordi Immunotherapeutics ๐บ๐ธ 
Hippocratic AI ๐บ๐ธ 
Artios Pharma ๐ฌ๐ง 
Lassie ๐ธ๐ช Latest Deals in Health
HEALTH LEAN ANALYTICS
$15M
Swiss startup Rivia has raised $15 million in a Series A funding round led by Earlybird, with participation from Defiant, Speedinvest, Amino Collective, and Nina Capital. The funding will support the development of a data platform that unifies clinical trial data, automating tasks that currently require significant manual effort. Rivia aims to reduce clinical trial costs by up to 50% and is already involved in about 40 trials across the U.S. and Europe, reporting fourfold growth in annual recurring revenue in 2025.
RIVIAInvestors: Earlybird, Defiant, Speedinvest, Amino Collective, Nina Capital
$15M
Rivia, a Zurich, Switzerland-based provider of a clinical trial data engine and AI platform, raised $15 million in Series A funding. The round was led by Earlybird, with participation from Defiant, Speedinvest, Amino Collective, and Nina Capital. The company plans to use the funds to expand its teams in Zurich and Boston and accelerate the rollout of its new suite of embedded AI agents.Investors: Earlybird, Defiant, Speedinvest, Amino Collective, Nina Capital
$2.268M
Barcelona-based startup Health Lean Analytics (HLA) has raised โฌ2.1 million in funding, including a โฌ1.4 million seed round from family offices and a loan from the Spanish National Innovation Company. HLA automates data collection in hospitals to reduce errors and improve patient care quality and safety. The funding will support international expansion, particularly in the U.S., and enhance R&D capabilities, with Novanta joining as a strategic partner to aid in technology validation.Investors: family offices, Spanish National Innovation Company
$8M
Manifold, a San Francisco-based company, has raised $8 million in seed funding to enhance security for autonomous AI agents operating in real-time. The funding round was led by Costanoa Ventures, with participation from Cherry Ventures, Rain Capital, and Modern Technical Fund. Manifold's platform addresses the blind spots of traditional security tools by tracking AI behavior directly, providing security teams with visibility into agent actions and enabling quick responses to anomalies.
MANIFOLDInvestors: Costanoa Ventures, Cherry Ventures, Rain Capital, Modern Technical Fund
$8M
Manifold, an AI detection and response platform, has raised $8 million in seed funding to enhance its technology for securing autonomous AI on enterprise endpoints. The funding round was led by Costanoa Ventures, with participation from Cherry Ventures, Rain Capital, Modern Technical Fund, and several angel investors. This investment aims to help organizations manage the risks associated with the growing use of autonomous AI agents.Investors: Costanoa Ventures, Cherry Ventures, Rain Capital, Modern Technical Fund
$8M
Manifold, a San Diego, CA-based provider of an AI detection and response platform for securing autonomous AI on endpoints, raised $8 million in seed funding. The round was led by Costanoa Ventures, with participation from Cherry Ventures, Rain Capital, Modern Technical Fund, and notable angels including former Uber CSO Joe Sullivan and former Google DeepMind CISO Vijay Bolina.Investors: Costanoa Ventures, Cherry Ventures, Rain Capital, Modern Technical Fund, Joe Sullivan, Vijay Bolina
$15M
Rivia, a Zurich-based data engine for clinical trial intelligence, has secured $15 million in a Series A funding round led by Earlybird, with participation from Defiant and existing investors Speedinvest, Amino Collective, and Nina Capital. The company addresses the fragmented infrastructure of clinical trial data by integrating diverse data sources in real time, enhancing decision-making. Rivia plans to launch AI agents to improve data quality monitoring and streamline workflows, responding to increasing regulatory scrutiny and declining industry returns.Investors: Earlybird, Defiant, Speedinvest, Amino Collective, Nina Capital
CONDUIT HEALTH
$1.62M
Ciaodott, an AI-powered voice assistant for the Italian healthcare sector, has raised โฌ1.5 million in a pre-seed funding round led by Techshop, with participation from Vento, Club degli Investitori, Growth Engine, and Alpha Venture. Founded in 2025, the company addresses the heavy telephone workload in medical centers by automating up to 70% of calls, allowing healthcare providers to focus on patient care. The funds will enhance Ciaodott's platform and expand its services across various medical specialties in Italy.
CIAODOTTInvestors: Techshop, Vento, Club degli Investitori, Growth Engine, Alpha Venture
$4.428M
Ternary Therapeutics, a London-based biotechnology company, has raised โฌ4.1 million (ยฃ3.6 million) in a seed funding round to enhance its AI-powered platform for drug discovery. The round was led by Daphni, with participation from Pace Ventures, the I&I Biotech Fund, and the UK Innovation & Science Seed Fund (UKI2S). The funding will help scale the platform and accelerate the development of molecular glue therapeutics.
TERNARY THERAPEUTICSInvestors: Daphni, Pace Ventures, I&I Biotech Fund, UK Innovation & Science Seed Fund
$1.62M
Ciaodott, a voice AI company for the Italian medical sector, has raised โฌ1.5 million in a pre-seed funding round led by Techshop, with participation from Vento, Club degli Investitori, Growth Engine, and Alpha Venture. Founded in 2025, Ciaodott addresses the issue of telephone overload in medical centers, managing 70% of calls to improve patient communication. The funds will enhance their platform and expand services to various medical specialties.Investors: Techshop, Vento, Club degli Investitori, Growth Engine, Alpha Venture
VST BIO
SEQUENTIAL
$4.428M
London-based biotech startup Ternary Therapeutics has raised โฌ4.1 million (ยฃ3.6 million) in seed funding to develop its AI platform for creating molecular glue medicines. The funding round was led by Daphni, with participation from Pace Ventures, the I&I Biotech Fund, and the UK Innovation & Science Seed Fund. Ternary aims to systematically design drugs targeting previously undruggable proteins, transforming drug discovery into a repeatable engineering process. The funding will help expand its teams and advance preclinical programs focused on inflammatory diseases.Investors: Daphni, Pace Ventures, I&I Biotech Fund, UK Innovation & Science Seed Fund
$5M
Understood Care, a New York City-based provider of an AI-native patient advocacy platform, raised $5 million in seed funding led by Rethink Education and Zeal Capital Partners. This funding follows a $3.4 million pre-seed round led by 1984 Ventures, with participation from Y Combinator. The company aims to use the funds to accelerate the development of Ava, its AI co-pilot, and strengthen partnerships.
UNDERSTOOD CAREInvestors: Rethink Education, Zeal Capital Partners, 1984 Ventures, Y Combinator
$8.4M
Understood Care has raised $8.4 million to enhance its AI-native patient advocacy platform, which assists patients in navigating the complexities of the U.S. healthcare system. The funding comprises a $5 million seed round led by Rethink Education and Zeal Capital Partners, along with $3.4 million in pre-seed funding led by 1984 Ventures, with participation from Y Combinator.Investors: Rethink Education, Zeal Capital Partners, 1984 Ventures, Y Combinator
$8.4M
Understood Care, an AI-native patient advocacy platform, has secured $8.4 million in funding, including a $5 million seed round led by Rethink Education and Zeal Capital Partners, along with $3.4 million in pre-seed funding led by 1984 Ventures and participation from Y Combinator. The funding will enhance the development of Ava, their AI co-pilot, to address the complexities of care navigation for America's aging population, improving access to healthcare services and reducing costs.Investors: Rethink Education, Zeal Capital Partners, 1984 Ventures, Y Combinator